Methylene Blue for Malaria Treatment in Africa
Author Information
Author(s): Peter E Meissner, Germain Mandi, Boubacar Coulibaly, Steffen Witte, Théophile Tapsoba, Ulrich Mansmann, Jens Rengelshausen, Wolfgang Schiek, Albrecht Jahn, Ingeborg Walter-Sack, Gerd Mikus, Jürgen Burhenne, Klaus-Dieter Riedel, Heiner Schirmer, Bocar Kouyaté, Olaf Müller
Primary Institution: Ruprecht-Karls-University, Heidelberg, Germany
Hypothesis
Is the combination of methylene blue and chloroquine effective for treating uncomplicated falciparum malaria in young children in Burkina Faso?
Conclusion
The study suggests that while methylene blue may have some efficacy against malaria, the combination with chloroquine is not effective for treatment in Africa.
Supporting Evidence
- Methylene blue has been used against malaria for over 100 years.
- The study included 435 children with uncomplicated falciparum malaria.
- The combination of methylene blue and chloroquine was not effective in treating malaria.
Takeaway
This study tested a new malaria treatment using methylene blue and found it doesn't work well when combined with chloroquine for kids in Africa.
Methodology
A single center uncontrolled trial with three dose levels of methylene blue combined with chloroquine was conducted on febrile children with uncomplicated malaria.
Potential Biases
Potential bias due to the uncontrolled nature of the trial and the reliance on self-reported outcomes.
Limitations
The study was uncontrolled and conducted over a short follow-up period of 14 days.
Participant Demographics
Children aged 6-59 months with uncomplicated malaria from Nouna, Burkina Faso.
Statistical Information
P-Value
pChi = 0.0233
Confidence Interval
[95% CI (7.5%, 14.0%)]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website